Jacqualyn A Fouse insider trades
Open-market stock purchases and sales by Jacqualyn A Fouse, Director at Agios Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 2, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +20%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | AGIO Agios Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 18, 2026 | AGIO Agios Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 18, 2026 | AGIO Agios Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 17, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 17, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 8, 2026 | INCY Incyte Corp | Bought (not open market) | — |
| Jun 8, 2026 | INCY Incyte Corp | Bought (not open market) | — |
Companies traded
- AGIO Agios Pharmaceuticals, Inc: 1 buy, 5 sales, last Jun 18, 2026
- MDGL Madrigal Pharmaceuticals, Inc: other filings, last Jun 17, 2026
- INCY Incyte Corp: other filings, last Jun 8, 2026
- DKS Dick's Sporting Goods, Inc: other filings, last Mar 22, 2020
- CELG Celgene Corp /de/: 6 buys, last Feb 14, 2017
- PRGO PERRIGO Co plc: other filings, last May 4, 2016
- BG Bunge Ltd: other filings, last Sep 2, 2010